That said, we believe that estimation of allelic state is not practically feasible in real time for clinical practice and that an allelic state measure agnostic to NGS‐based LOH may be more suitable for TP53 mutated myeloid neoplasms more so only in the absence of a CK. The gene discussed is TP53; the disease is myeloid neoplasm.